NKECHI ONWUCHE: Open Payments
NPI 1326409988 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,789 in 83 payments from 10 companies in 2025. Trend: 2023 $416 · 2024 $1,215 · 2025 $1,789
Food & beverage: $1,734Education: $55
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 26 | $482 |
| Lundbeck LLC | 16 | $334 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $250 |
| Alkermes, Inc. | 10 | $198 |
| Janssen Pharmaceuticals, Inc | 3 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $120 |
| Teva Pharmaceuticals USA, Inc. | 4 | $89 |
| Neurocrine BioSciences, Inc. | 3 | $82 |
| Vanda Pharmaceuticals Inc. | 2 | $68 |
| ABBVIE INC. | 2 | $43 |
Products named: COBENFY, ABILIFY ASIMTUFII, CAPLYTA, ARISTADA, INVEGA SUSTENNA, INGREZZA, FANAPT, UZEDY.
Industry payments across DC — which companies pay providers there.
